HIV protease inhibitors block oral epithelial cell DNA synthesis

Robert J Danaher1, Chunmei Wang, Andrew T Roland

  • 1Department of Oral Health Practice, University of Kentucky, Lexington, KY 40536-0297, USA.

Archives of Oral Biology
|December 29, 2009
PubMed
Abstract

Insights

Certain HIV protease inhibitors (PIs) reduce oral epithelial cell proliferation by inhibiting DNA synthesis. This finding may explain adverse oral health effects associated with PI therapy.

Area of Science:

  • Cell Biology
  • Pharmacology
  • Oral Health

Background:

  • Anti-retroviral therapy (ART) regimens containing HIV protease inhibitors (PIs) are linked to adverse effects like oral warts and gastrointestinal issues.
  • These side effects suggest PIs may impact epithelial cell biology, particularly in the oral cavity.

Purpose of the Study:

  • To investigate the effects of PIs on the biological processes of oral epithelium.
  • To determine if PIs perturb oral epithelial cell function.

Main Methods:

  • Oral keratinocytes and squamous carcinoma cells were cultured with pharmacologically relevant concentrations of PIs.
  • Cell viability, cytotoxicity, and DNA synthesis were assessed using enzymatic assays and BrdU incorporation.

Main Results:

  • Select PIs significantly reduced the viability of oral epithelial cells at plasma-relevant concentrations.
  • Nelfinavir was the most potent inhibitor, followed by lopinavir and saquinavir.
  • Reduced viability was attributed to the inhibition of DNA synthesis, not cytotoxicity.

Conclusions:

  • Certain PIs inhibit oral epithelial cell proliferation in a drug- and dose-dependent manner by blocking DNA synthesis.
  • This mechanism may explain some of the adverse oral health effects observed in patients on PI-based ART.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...